BI
Badr Ilmaguook
Credentials:
History
- 2023–2026
Residency
- 2019–2023
Medical School
Research
Elafibranor: a breakthrough therapy revolutionizing primary biliary cholangitis (PBC) treatment
Letter or commentary · Annals of Medicine and Surgery · 2025
Mavorixafor, CXCR4 antagonist, a novel treatment for WHIM syndrome, first FDA approval 2024
Letter or commentary · Annals of Medicine and Surgery · 2025
- HH
2 papers · 2 as a resident
1 paper